BIOORTHOGONAL COMPOUNDS COMPRISING A PROPARGYL GROUP FOR TREATING CANCER

Belen Rubio Ruiz (Inventor), Thomas Bray (Inventor), Ana Perez-Lopez (Inventor), Asier Unciti-Broceta (Inventor), Catherine Adam (Inventor)

Research output: Patent

Abstract

A method of preparing an active agent or a salt thereof from a prodrug first compound (1) comprising a propargyl group connected to an oxygen that is directly or indirectly connected to the active agent is provided, wherein the bond between the propargyl group and the oxygen is cleaved by reacting the first compound with palladium or gold, thereby releasing the active agent. Prodrug compositions suitable for use in the method are also provided.
Original languageEnglish
Patent numberWO/2017/199028
IPCC07H 15/252 (2006.01), C07H 19/06 (2006.01), C07H 17/08 (2006.01), A61K 31/12 (2006.01), A61K 31/417 (2006.01), A61K 31/437 (2006.01), A61K 31/496 (2006.01), A61K 31/513 (2006.01), A61K 31/704 (2006.01), C07C 259/06 (2006.01), A61K 31/7048 (2006.01), C07D 233/64 (2006.01), C07D 237/32 (2006.01), C07D 239/52 (2006.01), C07D 491/147 (2006.01)
Priority date18/05/16
Publication statusPublished - 23 Nov 2017

Fingerprint Dive into the research topics of 'BIOORTHOGONAL COMPOUNDS COMPRISING A PROPARGYL GROUP FOR TREATING CANCER'. Together they form a unique fingerprint.

Cite this